Chuikyo weighs ¥860,000 price tag for a post-prostate-surgery incontinence device
ADR Biomedical's male incontinence cell-therapy kit went before Japan's central insurance council on September 16 with a proposed ¥860,000 reimbursement price and a December 1 coverage target, both still pending formal government notification.